Association of HLA alleles with Plasmodium falciparum severity in Malian children

Tissue Antigens

Volumn 77, Issue 6, 2011, Pages 562-571

  Lyke, K E ^a   Fernandez Vina M A ^b   Cao, K ^c,d   Hollenbach, J ^e   Coulibaly, D ^f   Kone, A K ^f   Guindo, A ^f   Burdett, L A ^g,h   Hartzman, R J ⁱ   Wahl, A R ^j   Hildebrand, W H ^j   Doumbo, O K ^f   Plowe, C V ^a   Sztein, M B ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF BAMAKO   (Mali)

^g NATIONAL CANCER INSTITUTE   (United States)

^h SAIC FREDERICK INC   (United States)

ⁱ GEORGETOWN UNIVERSITY   (United States)

^j UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Children; Human leukocyte antigen class I; Human leukocyte antigen class II; Malaria; Mali; Plasmodium falciparum

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ALLELE; ARTICLE; BINDING AFFINITY; BRAIN DISEASE; BRAIN MALARIA; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; HLA SYSTEM; HUMAN; HUMAN CELL; INFANT; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; SCHOOL CHILD;

ADOLESCENT; ALGORITHMS; ALLELES; CHILD; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-A ANTIGENS; HUMANS; INFANT; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALARIA, FALCIPARUM; MALI; ODDS RATIO; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC;

MALIA; PLASMODIUM FALCIPARUM;

EID: 79956147654     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01661.x     Document Type: Article

References (49)

1. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005: 77: 171-92.
2. Hedrick P. Estimation of relative fitnesses from relative risk data and the predicted future of haemoglobin alleles S and C. J Evol Biol 2004: 17: 221-24.
3. Agarwal A, Guindo A, Cissoko Y et al. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood 2000: 96: 2358-63.
4. Modiano G, Morpurgo G, Terrenato L et al. Protection against malaria morbidity: near-fixation of the alpha-thalassemia gene in a Nepalese population. Am J Hum Genet 1991: 48: 390-97.
5. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976: 295: 302-04.
6. Bienzle U, Ayeni O, Lucas AO, Luzzatto L. Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant. Lancet 1972: 1: 107-10.
7. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez-Vina MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 2001: 62: 1009-30.
8. Hill AV, Allsopp CE, Kwiatkowski D et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991: 352: 595-600.
9. Hill AV, Elvin J, Willis AC et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria [see comments]. Nature 1992: 360: 434-39.
10. Aidoo M, Lalvani A, Gilbert SC et al. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Infect Immun 2000: 68: 227-32.
11. Bouharoun-Tayoun H, Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 1992: 60: 1473-81.
12. May J, Lell B, Luty AJ, Meyer CG, Kremsner PG. HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections. J Infect Dis 2001: 183: 168-72.
13. Hananantachai H, Patarapotikul J, Ohashi J, Naka I, Looareesuwan S, Tokunaga K. Polymorphisms of the HLA-B and HLA-DRB1 genes in Thai malaria patients. Jpn J Infect Dis 2005: 58: 25-8.
14. Busson M, Vu TA, Labelle P et al. HLA-DRB1 and DQB1 allele distribution in the Muong population exposed to malaria in Vietnam. Tissue Antigens 2002: 59: 470-74.
15. Osafo-Addo AD, Koram KA, Oduro AR, Wilson M, Hodgson A, Rogers WO. HLA-DRB1*04 allele is associated with severe malaria in northern Ghana. Am J Trop Med Hyg 2008: 78: 251-55.
16. Ovsyannikova IG, Jacobson RM, Ryan JE, Dhiman N, Vierkant RA, Poland GA. Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination. Clin Vaccine Immunol 2007: 14: 115-22.
17. Lyke KE, Burges R, Cissoko Y et al. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 2004: 72: 5630-37.
18. Coulibaly D, Diallo DA, Thera MA et al. Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Am J Trop Med Hyg 2002: 67: 604-10.
19. Lyke KE, Dicko A, Kone A et al. Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. Vaccine 2004: 22: 3169-74.
20. Lyke KE, Diallo DA, Dicko A et al. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am J Trop Med Hyg 2003: 69: 253-59.
21. Lyke KE, Burges RB, Cissoko Y et al. HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls. Infect Immun 2005: 73: 5799-808.
22. Diallo DA, Doumbo OK, Plowe CV, Wellems TE, Emanuel EJ, Hurst SA. Community permission for medical research in developing countries. Clin Infect Dis 2005: 41: 255-59.
23. Cao K, Chopek M, Fernandez-Vina MA. High and intermediate resolution DNA typing systems for class I HLA-A, B, C genes by hybridization with sequence-specific oligonucleotide probes (SSOP). Rev Immunogenet 1999: 1: 177-208.
24. Tu B, Mack SJ, Lazaro A et al. HLA-A, -B, -C, -DRB1 allele and haplotype frequencies in an African American population. Tissue Antigens 2007: 69: 73-85.
25. Middleton D. HLA-A and -B typing by SSOP. Newsletter, European Federation for Immunogenetics 1998: 23: 16-18.
26. Cao K, Moormann AM, Lyke KE et al. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 2004: 63: 293-325.
27. Nielsen M, Lundegaard C, Worning P et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003: 12: 1007-17.
28. Bui HH, Sidney J, Peters B et al. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 2005: 57: 304-14.
29. Peters B, Sette A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 2005: 6: 132.
30. Kyriacou HM, Stone GN, Challis RJ et al. Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Mol Biochem Parasitol 2006: 150: 211-18.
31. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J Royal Stat Soc 1977: 39: 1-38.
32. Lancaster A, Nelson M, Single R, Meyer D, Thomson G. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. Pac Symp Biocomp (Pacific Symposium Biocomputing) 2003: 514-25.
33. Lancaster A, Nelson M, Single R, Meyer D. Software framework for the biostatistics core. 2006: 1: 510-17.
34. Single R, Meyer D, Thomson G. Statistical methods for analysis of population genetic data. In: Hansen JA ed. Immunobiology of the Human MHC. Proceedings of the 13th International Histocompatibility Workshop and Conference, Vol. 1. Seattle: IHWG Press, 2006: 518-22.
35. Payami H, Joe S, Farid NR et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989: 45: 541-46.
36. Thomson G, Valdes AM. Conditional genotype analysis: detecting secondary disease loci in linkage disequilibrium with a primary disease locus. BMC Proceedings 2007: 1: S163.
37. Krausa P, Munz C, Keilholz W et al. Definition of peptide binding motifs amongst the HLA-A*30 allelic group. Tissue Antigens 2000: 56: 10-18.
38. Sidney J, Grey HM, Southwood S et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum Immunol 1996: 45: 79-93.
39. Lamberth K, Roder G, Harndahl M et al. The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype. Immunogenetics 2008: 60: 633-43.
40. Ramezani A, Aghakhani A, Kalantar E, Banifazl M, Eslamifar A, Velayati AA. HLA-A *3303* and *3301 predispose patients to persistent hepatitis B infection. J Gastrointestin Liver Dis 2009: 18: 117-18.
41. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature 2002: 415: 673-79.
42. Imai Y, Kamiyama T. T lymphocyte-dependent development of cerebral symptoms in WM/Ms rats infected with Plasmodium berghei. Ann Trop Med Parasitol 1994: 88: 83-5.
43. Belnoue E, Kayibanda M, Vigario AM et al. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol 2002: 169: 6369-75.
44. Hermsen C, van de WT, Mommers E, Sauerwein R, Eling W. Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology 1997: 114 (Pt 1): 7-12.
45. Ho M, Sexton MM, Tongtawe P, Looareesuwan S, Suntharasamai P, Webster HK. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J Infect Dis 1995: 172: 838-44.
46. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002: 8: 240-46.
47. Clark IA, Awburn MM, Harper CG, Liomba NG, Molyneux ME. Induction of HO-1 in tissue macrophages and monocytes in fatal falciparum malaria and sepsis. Malar J 2003: 2: 41.
48. Hoffman SL, Oster CN, Mason C et al. Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol 1989: 142: 1299-303.
49. Weiss WR, Mellouk S, Houghten RA et al. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 1990: 171: 763-73.